Τόμος 18 (2000) – Τεύχος 1 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 18 (2000) – Issue 1 – Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Βασίλης  Κόκκας

Εργαστήριο Φαρμακολογίας, Ιατρικό Τμήμα Αριστοτέλειο Πανεπιστήμιο, Θεσσαλονίκη, Ελλας

B. Kokkas

Department of Pharmacology, Medical School, Aristotle University, Thessaloniki, Greece

2. Γκίμπα Ο. Παππάς Κ.: Φυσιολογία. Θεσσαλονίκη (1984)

3. Αγιος Α.: Περιγραφική και εφηρμοσμένη ανατομική. Uni­versity Studio Press, Θεσσαλονίκη, 1997

4. Despotopoulos A., Silbernagl S.: Color atlas of physiol­ogy. Thieme Verlag, Stuttgart, 1991

5. Guyton A., Hall J.: Textbook of physiology. W.B. Saun­ders Company, Philadelphia, 1996

6. Κόκκας Β.: Σύστημα οξειδασών μικτής λειτουργίας και μεταβολισμός των φαρμάκων. Επιστ. Επετ. Ιατρ. Τμ. ΑΠΘ 24: 117-126 (1997)

7. Παραδέλλης Α.: Κλινική Φαρμακολογία. University Stu­dio Press, Θεσσαλονίκη, 1992

8. Correia M.: Drug biotransformation. In: (Katzung B., ed.) Basic and clinical pharmacology. Pp. 48-59, Prentice Hall In­tern. Inc., Con. USA, 1995

9. Benet L., Kroetz D., Sheiner L.: Pharmacokinetics. In: (Hardman J., Limbird L., eds) Goodman and Gilman’s. The pharmacological basis of therapeutics. Pp. 3-27, McGraw-Hill, New York, 1996

10. Παραδέλλης Α.: Αλληλεπιδράσεις φαρμάκων. Univer­sity Studio Press. Θεσσαλονίκη (1990)

11. Kinloch R., Treherne J., Furness L. Hajimohamadreze I.: The pharmacology of apoptosis. Trends Pharmacol. Sci. 20: 35-42 (1999)

12. Bass N.: Toxic and drug induced liver disease. In (Bennet J.C., Plum F., eds) Cecil: Textbook of medicine. Pp. 772-773, W.B. Saunders Comp., Philadelphia, 1996

13. Laurence D., Bennett P.: Clinical pharmacology. Churchil Livingstone, 1987

14. Wood A.,, Oates J.: Adverse reaction to drugs. In: (Wilson E. et al., eds) Harisson’s. Principles of internal medicine. Pp. 373-380, McGraw-Hill Inc., New York, 1991

15. Αndreoli T. et al eds: Cecil essentials of medicine. Pp. 315-325, Saunders W. Co, Philadelphia, 1990

16. Tredger M., Neuberger J., Williams R.: Drugs in acute hepatic necrosis. In: (Testa B., Perrissoud D., eds) Liver drugs. From the experimental pharmacology to therapeutic application. Pp. 67-80, CRC Press Inc, Boca Raton Florida, 1988

17. Brown M., Goldstein J.: The hyperlipoproteinemias and other disorders of lipid metabolism. In: (Wilson E., et al. eds) Harisson’s Principles of internal medicine. Pp. 1814-1825, McGraw-Hill Inc., New York, 1991

18. Sewell P.: Acute and chronic viral hepatitis. In: (Rakel P. et al., eds) Conn’s. Current therapy. Pp 446-480, W.B. Saunders Comp., Philadelphia, 1989

19. Τριανταφυλλόπουλος Γ., Θεοχαρίδης Θ.: Φάρμακα για τη θεραπεία πεπτικών και ηπατικών παθήσεων. Εις: (Θεοχαρίδης Θ.) Φαρμακολογία. Βασικές ιατρικές έννοιες στην κλινική πράξη. Σελ. 521-543, Ιατρικές εκδόσεις Λίτσας, Αθήνα, 1997

20. Diestag J. Isselbacher K.: Chronic hepatitis. In (Wilson E. et al., eds) Harisson’s Principles of internal medicine. Pp. 1696-1704, McGraw-Hill Inc., New York, 1998

21. Ockner R.: Chronic hepatitis. In: (Bennet J.C., Plum F., eds) Cecil. Textbook of medicine. Pp. 776-781, W.B. Saunders Comp., Philadelphia, 1996

22. Witzum J.: Drugs used in the treatment of hyperlipo­pro­teinemias. In: (Hardman J., Limbird L., eds) Goodman and Gilman’s. The pharmacological basis of therapeutics. Pp. 875-897, McGraw-Hill, New York, 1996

23. Malloy M., Kane J.: Agents used in hyperlipidemia In: (Katzung B., ed.) Basic and clinical pharmacology. Pp. 522-535, Prentice Hall Intern. , Con. USA, 1995

24. Κόκκας Β. και Kοτρίδης Π.: Υπολιπιδαιμικά φάρμακα. Επιθ. Κλιν. Φαρμακολ. Φαρμακοκιν. 9: 15-19 (1991)

25. Tracy J., Webster L.: Drugs used in the chemotherapy of helminthiasis. In: (Hardman J., Limbird L., eds) Good-man and Gilman’s. The pharmacological basis of thera­peutics. Pp. 1009-1026, McGraw-Hill, New York, 1996

26. Goldsmith R.: Clinical pharmacology of the anthelminthic drugs In: (Katzung B., ed.) Basic and clinical pharmacology.. Pp. 804-822, Prentice Hall Intern. Inc., Con. USA, 1995

27. Maddrey W.: Parasitic, bacterial, fungal and granulo­mat­ous liver disease. In: Bennet J.C., Plum F., eds) Cecil. Textbook of medicine. Pp. 781-785, B. Saunders Comp., Philadelphia, 1996

28. Eck St., Wilson J.: Gene – based therapy In: (Hardman J., Limbird L., eds) Goodman and Gilman’s. The pharma­cological basis of therapeutics. Pp. 77-101, McGraw-Hill, New York, 1996

29. Grossman M., Raper S., Kozarsky K., Stein E., Engel­hardt J., Muller D., Lupien D. and Wilson J.: Succesful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat. Gen. 6: 335-341 (1994)

30. Μουρελάτος Δ.: Γονιδιακή θεραπεία. Γενετική μηχανική και δεοντολογία. Ιατρική 70: 206-213 (1996)

31. Κόκκας Β.: Θέματα μοριακής φαρμακολογίας. Univer­sity Studio Press, Θεσσαλονίκη, 1999

32. Diasto R., LoBuglio A.: Immunomodulators. In: (Hardman J., Limbird L., eds) Goodman and Gilman’s. The pharma­cological basis of therapeutics. Pp. 1230-1308, McGraw-Hill, New York, 1996

33. Baldessarini R.: Drugs and the treatment of phychiatric disorders. In: (Hardman J., Limbird L., eds) Goodman and Gilman’s. The pharmacological basis of therapeutics. Pp. 431-459, McGraw-Hill, New York, 1996

34. Reisine T., Pasternac G.: Opioid analgesics and antagonists. In: (Hardman J., Limbird L., eds) Goodman and Gilman’s. The pharmacological basis of therapeutics. Pp. 521-555, McGraw-Hill, New York, 1996

35.  Farber E.: Response patterns of the liver to injury. In: (Testa B., Perrissoud D., eds) Liver drugs. From the ex­perimental pharmacology to therapeutic application. Pp. 1-14, CRC Press Inc., Boca Raton Florida, 1988